Results from the 5-year SQ grass SLIT-tablet asthma prevention (GAP) trial in children with grass pollen allergy
OPEN The Journal of allergy and clinical immunology | 12 Jul 2017
E Valovirta, TH Petersen, T Piotrowska, MK Laursen, JS Andersen, HF Sørensen and R Klink
Allergy immunotherapy targets the immunological cause of allergic rhinoconjunctivitis and allergic asthma and has the potential to alter the natural course of allergic disease.
* Data courtesy of Altmetric.com